Abstract
The use of nanobiomaterials is increasing each day. Among the immense variety of nanomaterials developed and studied the hydroxyapatite is one of the most ones. In this study we developed and tested nano-hydroxyapatite dopped with Ho-166 for bone cancer. The results showed that the nano-hydroxyapatite dopped with Ho-166 has a great affinity for the bone. The pre-clinical studies support the use as a nano-radiopharmaceuticals for bone cancer treatment and diagnosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
